PCDHGC3 silencing promotes renal carcinoma metastasis via mTOR/HIF2a and lipid metabolism rewiring
Lucía Celada, Tamara Cubiella, Jaime San‐Juan‐Guardado, Álvaro Suárez‐Priede, Nerea Gomez-Suarez, Laura Salerno, Eduardo Murias, Marina Da Silva Torres, Joshua A. Weiner, Helena Herrada‐Manchón, M. Alejandro Fernández, María‐Dolores Chiara
This study shows that silencing PCDHGC3 promotes renal carcinoma metastasis through mTOR/HIF2a activation and lipid metabolism changes.
Cell Death and Disease · Mar 26, 2026Peer-reviewedCancer Biology